The partnership, dubbed Ireland BioBridge, will focus on advancing health and life science through collaboration, commercialization, innovation and research, according to a May 10 press release.
The aim of the collaboration is to improve patient health and care experience through innovative medical devices, digital health solutions, therapeutics and research that will focus on identifying opportunities for clinical research and clinical trial activities.
The partnership, which was finalized May 9, is Texas Medical Center’s fourth international partnership.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
